Patents by Inventor Christopher P. Kiritsy

Christopher P. Kiritsy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NIACIN MIMETICS, AND METHODS OF USE THEREOF
    Publication number: 20160030441
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Application
    Filed: August 31, 2015
    Publication date: February 4, 2016
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Christopher P. Kiritsy, Wengen Wu
  • Niacin mimetics, and methods of use thereof
    Patent number: 9212142
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: December 15, 2015
    Assignees: Trustees of Tufts College, Arisaph Pharmaceuticals, Inc.
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Wengen Wu, Christopher P. Kiritsy
  • Niacin Mimetics, and Methods of Use Thereof
    Publication number: 20150094303
    Abstract: Disclosed are heterocyclylalkyl-substituted and heteroaralkyl-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Application
    Filed: December 10, 2014
    Publication date: April 2, 2015
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Wengen Wu, Christopher P. Kiritsy
  • Niacin mimetics, and methods of use thereof
    Patent number: 8937063
    Abstract: Disclosed are heterocyclylalkyl-substituted and heteroaralkyl-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: January 20, 2015
    Assignees: Trustees of Tufts College, Arisaph Pharmaceuticals, Inc.
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Wengen Wu, Christopher P. Kiritsy
  • Niacin Mimetics, and Methods of Use Thereof
    Publication number: 20140018359
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Application
    Filed: May 1, 2013
    Publication date: January 16, 2014
    Applicants: Arisaph Pharmaceuticals
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel Philip O'Connell, Wengen Wu, Christopher P. Kiritsy
  • Niacin mimetics, and methods of use thereof
    Patent number: 8450316
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: May 28, 2013
    Assignees: Trustees of Tufts College, Arisaph Pharmaceuticals, Inc.
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel Philip O'Connell, Wengen Wu, Christopher P. Kiritsy
  • NIACIN MIMETICS, AND METHODS OF USE THEREOF
    Publication number: 20120077807
    Abstract: Disclosed are 6-(morpholinoalkyl)-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Application
    Filed: June 24, 2011
    Publication date: March 29, 2012
    Applicant: Trustees of Tufts College
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Wengen Wu, Christopher P. Kiritsy
  • Niacin Mimetics, and Methods of Use Thereof
    Publication number: 20120077808
    Abstract: Disclosed are heterocyclylalkyl-substituted and heteroaralkyl-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.
    Type: Application
    Filed: June 24, 2011
    Publication date: March 29, 2012
    Applicant: Trustees of Tufts College
    Inventors: William W. Bachovchin, Hung-sen Lai, Daniel P. O'Connell, Wengen Wu, Christopher P. Kiritsy